Disrupting the CH1 domain structure in the acetyltransferases CBP and p300 results in lean mice with increased metabolic control

Cell Metabolism

Volumn 14, Issue 2, 2011, Pages 219-230

  Bedford, David C ^a   Kasper, Lawryn H ^a   Wang, Ruoning ^a   Chang, Yunchao ^a   Green, Douglas R ^a   Brindle, Paul K ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOVINE INSULIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; GLUCAGON; GLUCOSE; HISTONE ACETYLTRANSFERASE PCAF; HUMAN INSULIN; INSULIN; ISOPHANE INSULIN; METFORMIN; MUTANT PROTEIN; SERINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DRUG MECHANISM; ENERGY BALANCE; FEMALE; GENE EXPRESSION; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; INSULIN SENSITIVITY; KNOCKOUT MOUSE; LEAN BODY WEIGHT; LIVER METABOLISM; MALE; METABOLIC REGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN;

ANIMALS; BLOOD GLUCOSE; CELLS, CULTURED; CREB-BINDING PROTEIN; DIET; ENERGY METABOLISM; FEMALE; GLUCONEOGENESIS; INSULIN; MALE; METFORMIN; MICE; MICE, KNOCKOUT; P300-CBP TRANSCRIPTION FACTORS; THINNESS;

MUS;

EID: 79960938560     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2011.06.010     Document Type: Article

References (46)

1. Allis, C.D., Berger, S.L., Cote, J., Dent, S., Jenuwien, T., Kouzarides, T., Pillus, L., Reinberg, D., Shi, Y., Shiekhattar, R., et al. (2007). New nomenclature for chromatin-modifying enzymes. Cell 131, 633-636.
2. Bedford, D.C., Kasper, L.H., Fukuyama, T., and Brindle, P.K. (2010). Target gene context influences the transcriptional requirement for the KAT3 family of CBP and p300 histone acetyltransferases. Epigenetics 5, 9-15.
3. Biddinger, S.B., and Kahn, C.R. (2006). From mice to men: insights into the insulin resistance syndromes. Annu. Rev. Physiol. 68, 123-158.
4. Brivet, M., Slama, A., Saudubray, J.M., Legrand, A., and Lemonnier, A. (1995). Rapid diagnosis of long chain and medium chain fatty acid oxidation disorders using lymphocytes. Ann. Clin. Biochem. 32, 154-159.
5. Buzzai, M., Bauer, D.E., Jones, R.G., Deberardinis, R.J., Hatzivassiliou, G., Elstrom, R.L., and Thompson, C.B. (2005). The glucose dependence of Akt-transformed cells can be reversed by pharmacologic activation of fatty acid beta-oxidation. Oncogene 24, 4165-4173.
6. Dames, S.A., Martinez-Yamout, M., De Guzman, R.N., Dyson, H.J., and Wright, P.E. (2002). Structural basis for Hif-1 alpha /CBP recognition in the cellular hypoxic response. Proc. Natl. Acad. Sci. USA 99, 5271-5276.
7. De Guzman, R.N., Martinez-Yamout, M.A., Dyson, H.J., and Wright, P.E. (2004). Interaction of the TAZ1 domain of the CREB-binding protein with the activation domain of CITED2: regulation by competition between intrinsically unstructured ligands for non-identical binding sites. J. Biol. Chem. 279, 3042-3049.
8. Feige, J.N., and Auwerx, J. (2007). Transcriptional coregulators in the control of energy homeostasis. Trends Cell Biol. 17, 292-301.
9. Freedman, S.J., Sun, Z.Y., Poy, F., Kung, A.L., Livingston, D.M., Wagner, G., and Eck, M.J. (2002). Structural basis for recruitment of CBP/p300 by hypoxia-inducible factor-1 alpha. Proc. Natl. Acad. Sci. USA 99, 5367-5372.
10. Freedman, S.J., Sun, Z.Y., Kung, A.L., France, D.S., Wagner, G., and Eck, M.J. (2003). Structural basis for negative regulation of hypoxia-inducible factor-1alpha by CITED2. Nat. Struct. Biol. 10, 504-512.
11. Fujii, K., Zhu, G., Liu, Y., Hallam, J., Chen, L., Herrero, J., and Shaw, S. (2004). Kinase peptide specificity: improved determination and relevance to protein phosphorylation. Proc. Natl. Acad. Sci. USA 101, 13744-13749.
12. Gu, J., Milligan, J., and Huang, L.E. (2001). Molecular mechanism of hypoxia-inducible factor 1alpha-p300 interaction. A leucine-rich interface regulated by a single cysteine. J. Biol. Chem. 276, 3550-3554.
13. Halberg, N., Khan, T., Trujillo, M.E., Wernstedt-Asterholm, I., Attie, A.D., Sherwani, S., Wang, Z.V., Landskroner-Eiger, S., Dineen, S., Magalang, U.J., et al. (2009). Hypoxia-inducible factor 1alpha induces fibrosis and insulin resistance in white adipose tissue. Mol. Cell. Biol. 29, 4467-4483.
14. He, L., Sabet, A., Djedjos, S., Miller, R., Sun, X., Hussain, M.A., Radovick, S., and Wondisford, F.E. (2009). Metformin and insulin suppress hepatic gluconeogenesis through phosphorylation of CREB binding protein. Cell 137, 635-646.
15. Herzig, S., Long, F., Jhala, U.S., Hedrick, S., Quinn, R., Bauer, A., Rudolph, D., Schutz, G., Yoon, C., Puigserver, P., et al. (2001). CREB regulates hepatic gluconeogenesis through the coactivator PGC-1. Nature 413, 179-183.
16. Hirschey, M.D., Shimazu, T., Goetzman, E., Jing, E., Schwer, B., Lombard, D.B., Grueter, C.A., Harris, C., Biddinger, S., Ilkayeva, O.R., et al. (2010). SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature 464, 121-125.
17. Kang-Decker, N., Tong, C., Boussouar, F., Baker, D.J., Xu, W., Leontovich, A.A., Taylor, W.R., Brindle, P.K., and Van Deursen, J.M. (2004). Loss of CBP causes T cell lymphomagenesis in synergy with p27(Kip1) insufficiency. Cancer Cell 5, 177-189.
18. Kasper, L.H., and Brindle, P.K. (2006). Mammalian gene expression program resiliency: the roles of multiple coactivator mechanisms in hypoxia-responsive transcription. Cell Cycle 5, 142-146.
19. Kasper, L.H., Boussouar, F., Ney, P.A., Jackson, C.W., Rehg, J., van Deursen, J.M., and Brindle, P.K. (2002). A transcription-factor-binding surface of coactivator p300 is required for haematopoiesis. Nature 419, 738-743.
20. Kasper, L.H., Boussouar, F., Boyd, K., Xu, W., Biesen, M., Rehg, J., Baudino, T.A., Cleveland, J.L., and Brindle, P.K. (2005). Two transactivation mechanisms cooperate for the bulk of HIF-1-responsive gene expression. EMBO J. 24, 3846-3858.
21. Kasper, L.H., Fukuyama, T., Biesen, M.A., Boussouar, F., Tong, C., de Pauw, A., Murray, P.J., van Deursen, J.M., and Brindle, P.K. (2006). Conditional knockout mice reveal distinct functions for the global transcriptional coactivators CBP and p300 in T-cell development. Mol. Cell. Biol. 26, 789-809.
22. Kasper, L.H., Lerach, S., Wang, J., Wu, S., Jeevan, T., and Brindle, P.K. (2010). CBP/p300 double null cells reveal effect of coactivator level and diversity on CREB transactivation. EMBO J. 29, 3660-3672.
23. Koo, S.H., Flechner, L., Qi, L., Zhang, X., Screaton, R.A., Jeffries, S., Hedrick, S., Xu, W., Boussouar, F., Brindle, P., et al. (2005). The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism. Nature 437, 1109-1114.
24. Kung, A.L., Rebel, V.I., Bronson, R.T., Ch'ng, L.E., Sieff, C.A., Livingston, D.M., and Yao, T.P. (2000). Gene dose-dependent control of hematopoiesis and hematologic tumor suppression by CBP. Genes Dev. 14, 272-277.
25. Le Lay, J., Tuteja, G., White, P., Dhir, R., Ahima, R., and Kaestner, K.H. (2009). CRTC2 (TORC2) contributes to the transcriptional response to fasting in the liver but is not required for the maintenance of glucose homeostasis. Cell Metab. 10, 55-62.
26. Lipina, C., Huang, X., Finlay, D., McManus, E.J., Alessi, D.R., and Sutherland, C. (2005). Analysis of hepatic gene transcription in mice expressing insulinin-sensitive GSK3. Biochem. J. 392, 633-639.
27. Marmorstein, R. (2001). Structure of histone acetyltransferases. J. Mol. Biol. 311, 433-444.
28. Matsumoto, M., Ogawa, W., Akimoto, K., Inoue, H., Miyake, K., Furukawa, K., Hayashi, Y., Iguchi, H., Matsuki, Y., Hiramatsu, R., et al. (2003). PKClambda in liver mediates insulin-induced SREBP-1c expression and determines both hepatic lipid content and overall insulin sensitivity. J. Clin. Invest. 112, 935-944.
29. Matt, T., Martinez-Yamout, M.A., Dyson, H.J., and Wright, P.E. (2004). The CBP/p300 TAZ1 domain in its native state is not a binding partner of MDM2. Biochem. J. 381, 685-691.
30. Newton, A.L., Sharpe, B.K., Kwan, A., Mackay, J.P., and Crossley, M. (2000). The transactivation domain within cysteine/histidine-rich region 1 of CBP comprises two novel zinc-binding modules. J. Biol. Chem. 275, 15128-15134.
31. Oike, Y., Hata, A., Mamiya, T., Kaname, T., Noda, Y., Suzuki, M., Yasue, H., Nabeshima, T., Araki, K., and Yamamura, K. (1999). Truncated CBP protein leads to classical Rubinstein-Taybi syndrome phenotypes in mice: implications for a dominant-negative mechanism. Hum. Mol. Genet. 8, 387-396.
32. Ramnanan, C.J., Edgerton, D.S., Rivera, N., Irimia-Dominguez, J., Farmer, B., Neal, D.W., Lautz, M., Donahue, E.P., Meyer, C.M., Roach, P.J., and Cherrington, A.D. (2010). Molecular characterization of insulin-mediated suppression of hepatic glucose production in vivo. Diabetes 59, 1302-1311.
33. Tanaka, T., Yoshida, N., Kishimoto, T., and Akira, S. (1997a). Defective adipocyte differentiation in mice lacking the C/EBPbeta and/or C/EBPdelta gene. EMBO J. 16, 7432-7443.
34. Tanaka, Y., Naruse, I., Maekawa, T., Masuya, H., Shiroishi, T., and Ishii, S. (1997b). Abnormal skeletal patterning in embryos lacking a single Cbp allele: a partial similarity with Rubinstein-Taybi syndrome. Proc. Natl. Acad. Sci. USA 94, 10215-10220.
35. Thorrez, L., Van Deun, K., Tranchevent, L.C., Van Lommel, L., Engelen, K., Marchal, K., Moreau, Y., Van Mechelen, I., and Schuit, F. (2008). Using ribosomal protein genes as reference: a tale of caution. PLoS ONE 3, e1854. 10. 1371/journal.pone.0001854.
36. Tilghman, S.M., Hanson, R.W., Reshef, L., Hopgood, M.F., and Ballard, F.J. (1974). Rapid loss of translatable messenger RNA of phosphoenolpyruvate carboxykinase during glucose repression in liver. Proc. Natl. Acad. Sci. USA 71, 1304-1308.
37. Tuteja, G., Jensen, S.T., White, P., and Kaestner, K.H. (2008). Cis-regulatory modules in the mammalian liver: composition depends on strength of Foxa2 consensus site. Nucleic Acids Res. 36, 4149-4157.
38. Wang, Y., Inoue, H., Ravnskjaer, K., Viste, K., Miller, N., Liu, Y., Hedrick, S., Vera, L., and Montminy, M. (2010). Targeted disruption of the CREB coactivator Crtc2 increases insulin sensitivity. Proc. Natl. Acad. Sci. USA 107, 3087-3092.
39. Xu, W., Kasper, L.H., Lerach, S., Jeevan, T., and Brindle, P.K. (2007). Individual CREB-target genes dictate usage of distinct cAMP-responsive coactivation mechanisms. EMBO J. 26, 2890-2903.
40. Yamauchi, T., Oike, Y., Kamon, J., Waki, H., Komeda, K., Tsuchida, A., Date, Y., Li, M.X., Miki, H., Akanuma, Y., et al. (2002). Increased insulin sensitivity despite lipodystrophy in Crebbp heterozygous mice. Nat. Genet. 30, 221-226.
41. Yao, T.P., Oh, S.P., Fuchs, M., Zhou, N.D., Ch'ng, L.E., Newsome, D., Bronson, R.T., Li, E., Livingston, D.M., and Eckner, R. (1998). Gene dosagedependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300. Cell 93, 361-372.
42. Yu, J., and Auwerx, J. (2009). The role of sirtuins in the control of metabolic homeostasis. Ann. N Y Acad. Sci. 1173 (Suppl 1 ), E10-E19.
43. Zanger, K., Radovick, S., and Wondisford, F.E. (2001). CREB binding protein recruitment to the transcription complex requires growth factor-dependent phosphorylation of its GF box. Mol. Cell 7, 551-558.
44. Zhang, X., Lam, K.S., Ye, H., Chung, S.K., Zhou, M., Wang, Y., and Xu, A. (2010). Adipose tissue-specific inhibition of hypoxia inducible factor 1{alpha} induces obesity and glucose intolerance by impeding energy expenditure in mice. J. Biol. Chem. 285, 32869-32877.
45. Zhao, S., Xu, W., Jiang, W., Yu, W., Lin, Y., Zhang, T., Yao, J., Zhou, L., Zeng, Y., Li, H., et al. (2010). Regulation of cellular metabolism by protein lysine acetylation. Science 327, 1000-1004.
46. Zhou, X.Y., Shibusawa, N., Naik, K., Porras, D., Temple, K., Ou, H., Kaihara, K., Roe, M.W., Brady, M.J., and Wondisford, F.E. (2004). Insulin regulation of hepatic gluconeogenesis through phosphorylation of CREB-binding protein. Nat. Med. 10, 633-637.